Purpose: To analyze the visual outcome of Boston keratoprosthesis for keratopathy in silicone oil-filled eyes.
Methods: Retrospective chart review of patients with silicone oil-induced keratopathy undergoing Boston keratoprosthesis between January 2008 and June 2010 was performed. Patients received Boston keratoprosthesis as the primary procedure or after a failed penetrating keratoplasty because of silicone oil-induced keratopathy after assessing possible visual potential. Silicone oil had to be retained in all eyes because of persistent ocular hypotony.
Results: Of the 8 eyes that underwent surgery, anatomic retention and visual improvement were noted in 7 eyes (87.5%). The visual acuity improved to 20/200 or better in 6 eyes (66.67%). Repeated corneal melt necessitated the removal of the prosthesis with corneal transplant in 1 eye. Membranectomy was performed twice for retroprosthetic membrane in 1 eye.
Conclusions: Boston keratoprosthesis seems to be a viable option for visual rehabilitation in postvitrectomized eyes with a decrease in vision due to retained silicone oil-induced keratopathy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/ICO.0b013e318213a8b5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
TNF-α Suppression Attenuates Limbal Stem Cell Damage in Ocular Injury.
Cornea
December 2024
Department of Ophthalmology, Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School, Boston, MA.
Purpose: Ocular chemical injuries often cause uveal inflammation, upregulation of TNF-α at the limbus, and subsequent limbal stem cell (LSC) damage. In this study, we investigate the protective role of TNF-α suppression in LSC survival.
Methods: Corneal alkali injuries were performed using NaOH as previously described by our group.
Risk factors for early and late retinal detachment after Boston type I keratoprosthesis surgery.
Graefes Arch Clin Exp Ophthalmol
December 2024
Centro de Oftalmología Barraquer, Barcelona, Spain.
Comments on risk factors for early and late retinal detachment after boston type I keratoprosthesis surgery.
Graefes Arch Clin Exp Ophthalmol
November 2024
Department of Ophthalmology, University of Montreal, Montreal, QC, Canada.
Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study.
J Clin Med
November 2024
Department of Ophthalmology, District Railway Hospital, 40-760 Katowice, Poland.
The purpose of this study is to evaluate clinical outcomes and early postoperative complications in patients undergoing Boston type I keratoprosthesis (BKPro) implantation, with a specific focus on the onset and nature of ocular surface disorders during the early postoperative period. This retrospective study included 77 eyes that underwent BKPro implantation between 2019 and March 2022. Patients were treated at the Saint Barbara Hospital, Trauma Centre, Sosnowiec, Poland, and District Railway Hospital, Katowice, Poland.
View Article and Find Full Text PDFTibial Bone Keratoprosthesis: Seeing into the Third Decade.
Ophthalmol Glaucoma
November 2024
Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!